Covered recipient · General Payments record
SUZANNE E SCHINDLER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$29,035.72
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,737.25 | 6 |
| Travel and Lodging | $2,244.12 | 8 |
| Food and Beverage | $596.85 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $10,902.70 | 6 |
| EISAI INC. | $7,358.08 | 8 |
| Lilly USA, LLC | $3,750.00 | 1 |
| Novo Nordisk AS | $1,500.00 | 1 |
| Beckman Coulter, Inc. | $67.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Beckman Coulter, Inc. | $67.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145197437 | CMS |
| Eisai Inc. | $104.00 | 02/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110784314 | CMS |
| Eisai Inc. | $143.55 | 02/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110784316 | CMS |
| Eisai Inc. | $104.00 | 02/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110784318 | CMS |
| Eisai Inc. | $322.23 | 02/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110784320 | CMS |
| Eisai Inc. | $216.64 | 02/07/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110784322 | CMS |
| Eisai Inc. | $4,680.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110784310 | CMS |
| Eisai Inc. | $1,755.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110784312 | CMS |
| Eisai Inc. | $32.66 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110784308 | CMS |
| Lilly USA, LLC | $3,750.00 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135422035 | CMS |
| Novo Nordisk AS | $1,500.00 | 07/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096552753 | CMS |
| Novo Nordisk Inc | $1,724.00 | 06/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096887766 | CMS |
| Novo Nordisk Inc | $496.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096944948 | CMS |
| Novo Nordisk Inc | $7,328.25 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097134435 | CMS |
| Novo Nordisk Inc | $522.02 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097323765 | CMS |
| Novo Nordisk Inc | $354.82 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097462491 | CMS |
| Novo Nordisk Inc | $476.86 | 06/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1097746456 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.